Atlas Trials

Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma

Clinical trial NCT05532397 · RECRUITING

Trial details

NCT number
NCT05532397
Sponsor
National University Hospital, Singapore
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioma, Astrocytic
Start date
2023-02-17
Primary completion
2026-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.